Robert Chess

Robert B. Chess was the founder of Penederm, Inc., founded in 1986, where the title held was President from 1986 to 1989.
Mr. Chess was the founder of Biota Technology, Inc., founded in 2013, where the title held was Chairman.
Current jobs include Chairman at Nektar Therapeutics since 2007, Chairman at Issio Solutions, Inc., Chairman at BigHat Biosciences, Inc. since 2022, Lead Independent Director at Twist Bioscience Corp.
since 2018, Director at NanOasis, Inc. since 2012, Director at Pelvalon, Inc., Trustee at California Institute of Technology since 2006, and Trustee at Committee for Economic Development.
Former jobs include Chairman & Chief Executive Officer at OPX Biotechnologies, Inc. from 2007 to 2015, Chairman at Germitec SA, Chairman at Bio Ventures for Global Health, Director at Pharsight Corp.
from 2000 to 2006, Director at CymaBay Therapeutics, Inc. in 2009, Director at CoTherix, Inc. from 2004 to 2007, Director at Biotechnology Innovation Organization from 2009 to 2009, Associate Director-Economic & Domestic Policy at The White House from 1990 to 1991, Principal at Intel Corp., and Principal at Metaphor Computer Systems, Inc. Education includes an MBA degree from Harvard University conferred in 1980 and undergraduate education at California Institute of Technology.